Image 1 of 1
BRUSSELS  -  BELGIUM  - 29 JUNE 2011 --  IF  and Bayer HealthCare Pharmaceuticals launch event of the report "Act against Europe's most common birth defects: one year on" at Radisson Blu EU Hotel. -- Panel discussion (from left) Yann Le Cam, CEO European Organisation for Rare Diseases (EURORDIS) and Pierre Mertens, President of the International Federation for Spina Bifida and Hydrocephalus (IF). --  PHOTO: Juha ROININEN /  EUP-IMAGES